PRESS RELEASE published on 11/13/2025 at 07:30, 8 months 1 day ago Stable earnings despite portfolio adjustment - 2025 guidance confirmed, strong growth in branded pharmaceuticals Dermapharm Holding SE reports stable earnings despite portfolio adjustments in Q3 2025, confirms 2025 guidance and strong growth in branded pharmaceuticals Pharmaceuticals Growth Earnings Dermapharm Holding SE Portfolio Adjustment
BRIEF published on 08/26/2025 at 07:35, 10 months 19 days ago Dermapharm annonce une activité stable au premier semestre 2025 et une croissance de l'EBITDA au deuxième trimestre Résultats Financiers Croissance De L'EBITDA Stabilité Des Revenus Produits Pharmaceutiques De Marque Performances De Dermapharm
BRIEF published on 08/26/2025 at 07:35, 10 months 19 days ago Dermapharm Reports Stable Business in H1 2025 and Q2 EBITDA Growth Financial Results EBITDA Growth Revenue Stability Branded Pharmaceuticals Dermapharm Performance
PRESS RELEASE published on 08/26/2025 at 07:30, 10 months 19 days ago Dermapharm confirms stable business development in H1 2025 and records EBITDA growth in Q2 versus prior-year quarter Dermapharm confirms stable business development in H1 2025 with EBITDA growth in Q2. Full-year guidance for 2025 reiterated. Branded pharmaceuticals main growth driver Revenue Pharmaceuticals EBITDA Growth Dermapharm H1 2025
BRIEF published on 08/12/2025 at 07:35, 11 months 2 days ago Dermapharm Holding SE Continues Growth in Q2 2025 Revenue Forecast EBITDA Growth Branded Pharmaceuticals Dermapharm Q2 2025 Performance
BRIEF published on 08/12/2025 at 07:35, 11 months 2 days ago Dermapharm Holding SE poursuit sa croissance au deuxième trimestre 2025 Prévisions De Revenus Croissance De L'EBITDA Produits Pharmaceutiques De Marque Dermapharm Performances Du Deuxième Trimestre 2025
PRESS RELEASE published on 08/12/2025 at 07:30, 11 months 2 days ago Dermapharm Holding SE remains on projected growth trajectory in Q2 2025 Dermapharm Holding SE reports Q2 2025 results in line with expectations. Confirms full-year guidance of EUR 1,160–1,200 million revenue and EUR 322–332 million EBITDA Pharmaceuticals EBITDA Growth Dermapharm Holding SE Full-year Guidance Q2 2025 Results
BRIEF published on 06/26/2025 at 17:48, 1 year ago Dermapharm Holding SE Approves EUR 0.90 Dividend Per Share Sustainability Dividend AGM Financial Outlook Dermapharm
BRIEF published on 06/26/2025 at 17:48, 1 year ago Dermapharm Holding SE approuve un dividende de 0,90 € par action Dividende Durabilité Assemblée Générale Annuelle Perspectives Financières Dermapharm
PRESS RELEASE published on 06/26/2025 at 17:43, 1 year ago Dermapharm Holding SE: Annual General Meeting resolves dividend distribution of EUR 0.90 per share Dermapharm Holding SE's Annual General Meeting approves divident distribution of EUR 0.90 per share for 2024, confirms 2025 outlook and ratifies Board actions Annual General Meeting Financial Year 2024 Dividend Distribution Dermapharm Holding SE EUR 0.90 Per Share
Published on 07/14/2026 at 01:45, 7 hours 49 minutes ago Arctic Fox Lithium Approved for Trading on the OTCQB Venture Market and Announces DTC Eligibility
Published on 07/14/2026 at 00:01, 9 hours 33 minutes ago Captor Capital Announces Delay in its Annual Filings
Published on 07/13/2026 at 23:10, 10 hours 24 minutes ago Galaxy Ventures Inc. Announces Director Resignation
Published on 07/13/2026 at 21:35, 11 hours 59 minutes ago ATHA Energy Announces Corporate Activities Update
Published on 07/13/2026 at 20:00, 13 hours 34 minutes ago IBC Announces Share-Based Compensation to Directors
Published on 07/14/2026 at 09:05, 28 minutes ago ORTEC acquires TOBA HR Solutions to strengthen healthcare workforce management in Belgium and Luxembourg
Published on 07/14/2026 at 09:05, 28 minutes ago ASIA'S 50 BEST BARS UNVEILS THE EXTENDED 51-100 LIST FOR 2026
Published on 07/14/2026 at 08:30, 1 hour 4 minutes ago RBI on the interim status of acceptances of the voluntary public tender offer for all Addiko shares as of 13 July 2026
Published on 07/13/2026 at 18:00, 15 hours 34 minutes ago CP Icade - Icade reprend 100% de la propriété de la Tour Eqho à la Défense
Published on 07/13/2026 at 18:00, 15 hours 34 minutes ago PR Icade - Icade regains full ownership of the Eqho Tower in La Défense
Published on 07/13/2026 at 18:00, 15 hours 34 minutes ago THERMADOR GROUPE : publication du chiffre d'affaires semestriel 2026
